WHO Issues Warning Over Critical Scarcity of Weight-Loss Medications
Under one in 10 patients that would benefit from GLP-1 drugs including Wegovy can access them, states the global health agency as it releases its first recommendations on the medications.
Given over a billion people worldwide currently classified as obese, it is advocating for increased and just availability to these injectable treatments.
Per estimates, over two billion are projected to be living with obesity by 2030 unless action is taken.
"Our new guidelines affirms that obesity is a chronic disease that can be addressed with comprehensive and continuous support," remarked its chief Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and distribution challenges are major hurdles to widespread access to the treatments that can help people shift considerable body mass, notes the organization.
Skinny Jab Supply Crisis
Despite the present most favorable scenario, the supply of such drugs might only reach about 100 million people – under 10% of the global need, as stated by the health organization.
The recommendation urges nations and manufacturers to widen availability, via approaches including voluntary licensing.
A patent on the active ingredient – the primary component of a leading brand – is scheduled to end in several nations in 2026.
The Way Obesity Drugs Work
The injections replicate a natural hormone to delay gastric emptying, reduce hunger and enhance the sense of being full so people consume fewer calories.
Patients typically begin shedding pounds within a few weeks of commencing the weekly injections.
Evidence points to people may put most of the weight back on a year later of stopping the medication, when their usual food cravings come back.
Being above a healthy weight raises your likelihood for developing health problems, like type 2 diabetes, cardiovascular issues, brain attack, and certain cancers.
Excess weight affects individuals in countries worldwide and was associated with 3.7 million deaths worldwide in 2024, as per the WHO.
